Biopharma PEG Scientific Inc.

Hydrophilic poly(ethylene glycol) or PEG-linkers are particularly attractive as a linker for conjugation.

Type 2 diabetes is the most common form of diabetes. Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin.